X-BIOTIX THERAPEUTICS, INC.

Lobbying client · Massachusetts · filed 2025 to 2026

biotechnology company

$10,000 Reported spend

5 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page is grouped by the client's LDA id (55837), not by name.

Firms hired 1

INNOVATIVE FEDERAL STRATEGIES, LLC $10,000 5 filings

Bills named in these filings 2

HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2 filings
S 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2 filings

Reported by year 2 years

2026 $0 1 filing
2025 $10,000 4 filings

Issues lobbied 1

Budget/Appropriations 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 3
SENATE 2

Recent filings 5 total

1TY

INNOVATIVE FEDERAL STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 20, 2026

View → Q4

INNOVATIVE FEDERAL STRATEGIES, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · posted Jan 20, 2026

View → Q3

INNOVATIVE FEDERAL STRATEGIES, LLC

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 20, 2025

View → Q2

INNOVATIVE FEDERAL STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · posted Jul 18, 2025

View → Q1

INNOVATIVE FEDERAL STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $10,000 income · posted Apr 16, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.